What We Know:
Patients with kidney disease develop brain disorders more rapidly and frequently than the general population. Their kidneys are unable to efficiently clear metabolic toxins from their body. This inadequate
removal of toxins can damage neurons and supporting cells in the central and peripheral nervous system leading to brain dysfunction.
Our Plan to Help:
Dr. Sedaghat’s research aims to identify toxic molecules that target the brain and can cause an excessive risk of cognitive impairment and memory loss. Findings of this proposal can potentially identify novel targets and pathways that can lead to the development and application of neuro-protective therapies resulting in lower burden of neurological disorders and improved quality of life in kidney disease patients.
How You Can Help:
Donate to the American Brain Foundation to support Dr. Sedaghat’s important research that may lead to improved treatments and therapies for patients with neurological disorders.
Dr. Sedaghat is the recipient of the 2019 McKnight Clinical Translational Research Scholarship in Cognitive Aging and Age-Related Memory Loss funded by the McKnight Brain Research Foundation through the American Brain Foundation and American Academy of Neurology.